Skip to content
★ Sign in to follow
CH

Catarina Hjelm

EQL Pharma AB
Total declarations
3
Company
1
▲ Purchases (1 ops.)
€9,579
▼ Sales (0 ops.)
—

Latest filing published 16 Nov 2018 for EQL Pharma AB.

Filing timeline

BuySale
Catarina Hjelm

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Catarina Hjelm: trading record in brief

Catarina Hjelm is a declared insider of EQL Pharma AB, with filings sourced from Finansinspektionen. We count 3 filings; the first trade dates from 22 October 2018 and the latest from 13 November 2018.

Purchases make up the whole of the open-market record (1 purchase, €9,579). Unlike grants, an open-market purchase is paid for by the insider, at the market price.

The record was last updated on 16 November 2018 with a transaction in EQL Pharma AB. The last insider purchase was made public on 23 October 2018, 2,939 days ago. Filings reach the Finansinspektionen feed a median of 3 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Catarina Hjelm

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ●
    Regulatory Affairs managerExecutivesEQL Pharma AB
    0FI-SE
    9,996 shares0TeckningsrättISIN SE0011844166FI:csv-c413c08eb7ef13221cce
  • ●
    Regulatory Affairs managerExecutivesEQL Pharma AB
    9,996 SEK0FI-SE
    1,666 shares@ SEK 6.009.2% of flowBTA (betald tecknad aktie)ISIN SE0011844174FI:csv-3352f877d0575c1f6056
  • ▲
    Regulatory affairs managerExecutivesEQL Pharma AB
    98,900 SEK31FI-SE
    10,000 shares@ SEK 9.8990.8% of flowAktieISIN SE0005497732FI:csv-91655ada9cba1b200e26
    Canonical exit: 20 Jan 2019 (T+90)

3 of 3 declarations